Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Steven Murphy: How Much Benefit Do Statins Really Provide for Cardiovascular Prevention
Steven AR Murphy MD/LinkedIn
Apr 8, 2026, 14:51

Steven Murphy: How Much Benefit Do Statins Really Provide for Cardiovascular Prevention

Steven Murphy, Medical Director of Concierge Medical Associates, shared a post on LinkedIn:

“‘These findings suggest that treating 100 adults (aged 50-75 years) without known cardiovascular disease with a statin for 2.5 years prevented 1 MACE in 100 adults Statins may help to prevent a first MACE in adults aged 50 to 75 years old if they have a life expectancy of at least 2.5 years.

There is no evidence of a mortality benefit.’

That’s the story from a 2020 Meta Analysis of Eight trials randomizing 65 383 adults (66.3% men) were identified.

The mean age ranged from 55 to 69 years old and the mean length of follow-up ranged from 2 to 6 years.

Only 1 of 8 studies showed that statins decreased all-cause mortality.

The meta-analysis results suggested that 2.5 (95% CI, 1.7-3.4) years were needed to avoid 1 MACE for 100 patients treated with a statin.

To prevent 1 MACE for 200 patients treated (ARR equals 0.005), the TTB was 1.3 (95% CI, 1.0-1.7) years, whereas the TTB to avoid 1 MACE for 500 patients treated (ARR equals 0.002) was 0.8 (95% CI, 0.5-1.0) years.

These findings suggest that treating 100 adults (aged 50-75 years) without known cardiovascular disease with a statin for 2.5 years prevented 1 MACE in 1 adult.

Statins may help to prevent a first MACE in adults aged 50 to 75 years old if they have a life expectancy of at least 2.5 years.

There is no evidence of a mortality benefit.

Prevent heart attack?

2.5 year of treatment to prevent 1 MI in 100 people.

Not exactly the longevity benefit I am looking for.

Those suggesting statins for longevity are clearly unaware of the ITP and should be directed there first.

The UK 🇬🇧 biobank data was more useful than influencer docs telling you to take statins.

Atorvastatin did not help at all….”

Title: Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years

Authors: Lindsey C Yourman, Irena S Cenzer, W John Boscardin, Brian T Nguyen, Alexander K Smith, Mara A Schonberg, Nancy L Schoenborn, Eric W Widera, Ariela Orkaby, Annette Rodriguez, Sei J Lee

Read the Full Article on JAMA Network

Steven Murphy: How Much Benefit Do Statins Really Provide for Cardiovascular Prevention

Title: Association between prescription drugs and all-cause mortality risk in the UK population

Authors: Jonas Morin, Yves Rolland, Heike A. Bischoff-Ferrari, Alejandro Ocampo, Kevin Perez

Read the Full Article on Aging Cell

Steven Murphy: How Much Benefit Do Statins Really Provide for Cardiovascular Prevention

Other posts featuring Steven Murphy on Hemostasis Today.

Aging Cell Alexander K Smith Annette Rodriguez Ariela Orkaby bleeding disorders Brian T Nguyen Cardiology Cardiovascular Disease Eric W Widera Health Heart Attack Hematology Hemostasis Hemostasis News Hemostasis Today Irena S Cenzer JAMA Network Lindsey C Yourman MACE Mara A Schonberg Medicine MI Nancy L Schoenborn Sei J Lee statins Steven Murphy thrombosis W John Boscardin
NewsFeed